Rhythm Pharmaceuticals, Inc. (RYTM)
112.28
+7.26
(+6.91%)
USD |
NASDAQ |
Nov 06, 16:00
112.70
+0.42
(+0.37%)
After-Hours: 20:00
Rhythm Pharmaceuticals EPS Diluted (TTM) : -2.913 for Sept. 30, 2026
EPS Diluted (TTM) Chart
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| September 30, 2026 | -2.913 |
| June 30, 2026 | -3.118 |
| March 31, 2026 | -3.138 |
| December 31, 2025 | -3.109 |
| September 30, 2025 | -3.103 |
| June 30, 2025 | -3.018 |
| March 31, 2025 | -2.815 |
| December 31, 2024 | -4.360 |
| September 30, 2024 | -4.338 |
| June 30, 2024 | -4.367 |
| March 31, 2024 | -4.638 |
| December 31, 2023 | -3.207 |
| September 30, 2023 | -3.259 |
| June 30, 2023 | -3.291 |
| March 31, 2023 | -3.363 |
| December 31, 2022 | -3.491 |
| September 30, 2022 | -3.589 |
| June 30, 2022 | -3.493 |
| March 31, 2022 | -3.305 |
| December 31, 2021 | -1.354 |
| September 30, 2021 | -1.291 |
| June 30, 2021 | -1.358 |
| March 31, 2021 | -1.359 |
| December 31, 2020 | -3.036 |
| September 30, 2020 | -3.028 |
| Date | Value |
|---|---|
| June 30, 2020 | -3.304 |
| March 31, 2020 | -3.841 |
| December 31, 2019 | -3.907 |
| September 30, 2019 | -3.868 |
| June 30, 2019 | -3.342 |
| March 31, 2019 | -2.615 |
| December 31, 2018 | -2.376 |
| September 30, 2018 | -2.045 |
| June 30, 2018 | -3.309 |
| March 31, 2018 | -3.579 |
| December 31, 2017 | -3.253 |
| September 30, 2017 | -3.106 |
| June 30, 2017 | -1.567 |
| March 31, 2017 | -1.010 |
| September 30, 2016 | -0.981 |
| June 30, 2016 | -0.8441 |
| March 31, 2016 | -0.6316 |
| December 31, 2015 | -0.4128 |
| September 30, 2015 | -0.1959 |
| December 31, 2014 | -0.1017 |
| September 30, 2014 | -0.1228 |
| June 30, 2014 | -0.1502 |
| March 31, 2014 | -0.1182 |
| June 30, 2013 | -0.0857 |
| March 31, 2013 | -0.0365 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 19.80 |
| BioMarin Pharmaceutical, Inc. | -0.1035 |
| Cytokinetics, Inc. | -6.038 |
| Exelixis, Inc. | 3.342 |
| Ionis Pharmaceuticals, Inc. | -3.473 |